Bashir Timol - 28 Jan 2022 Form 4 Insider Report for Nemaura Medical Inc.

Role: Chief Business Officer, Director, 10%+ Owner
Signature: /s/ Bashir Timol
Issuer symbol: N/A
Transactions as of: 28 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Feb 2022, 15:07:28 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NMRD	Common Stock						2,708,210	28 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NMRD	Stock Option (right to buy)	Award	$0	+8,000		$0.000000	8,000	28 Jan 2022	Common Stock	8,000	$3.98	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the issuer's Board of Directors granted the reporting person an option to purchase 8,000 shares of the issuer's common stock at an exercise price of $3.98 per share. The option was fully vested at grant and expires on January 28, 2027.